 Stock analysts at Cantor Fitzgerald assumed coverage on shares of Applied Genetic Technologies NASDAQ:AGTC in a report issued on Monday, Marketbeat reports. The brokerage set an overweight rating and a 14.00 price target on the biotechnology companys stock. Cantor Fitzgeralds price objective suggests a potential upside of 107.41 from the companys previous close. Several other ... 